Stock NAUT NAUTILUS BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Nautilus Biotechnology, Inc.

Equities

NAUT

US63909J1088

Market Closed - Nasdaq
Other stock markets
 21:00:00 28/06/2024 BST 		5-day change 1st Jan Change
2.34 USD +2.63% Intraday chart for Nautilus Biotechnology, Inc. -4.49% -21.74%
06-27 Guggenheim Initiates Nautilus Biotechnology at Buy With $6 Price Target MT
06-10 Transcript : Nautilus Biotechnology, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:40 AM

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Nautilus Biotechnology Expands to San Diego
Nautilus Biotechnology, Translational Genomics Research Institute Team Up to Advance Study in Childhood Cancer
Nautilus Biotechnology, Inc. Partners with the Translational Genomics Research Institute to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma
Nautilus Biotechnology, Inc. Appoints Karen Akinsanya to Nominating Committee
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
NAUTILUS : le fabricant de produits de fitness étudie la possibilité d'une vente
Exode chez Peloton, Biogen paye, Nautilus souffre, Meta s'excuse : Planète Bourse du mardi 27 septembre
Nautilus Biotechnology Shares Rise After Company's Q2 Loss Narrows
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Nautilus Biotechnology, Inc. Appoints Gwen Weld as Chief People Officer
Nautilus Biotechnology, Inc. Appoints Karen Akinsanya to Board of Directors
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NAUT Stock
  4. News Nautilus Biotechnology, Inc.
  5. Other languages